knowledge -WSS

knowledge

author：entertainment 2025-09-04 02:34:23 - browse：75

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： How generative AI is inspiring dreams of a health data revolution

WSS

How to protect patients from sexual assault

FDA panel signals lack of confidence in Amgen cancer drug data

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

VC firm General Catalyst wants to buy a health system

AstraZeneca chief proposes a novel edit to the drug pricing bill

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

hotspot

knowledge

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

When women are denied an abortion, their children fare worse than peers

Moonlake's readout produced a cash windfall. Risks remain

Was Amgen transparent enough on FDA's concern on cancer drug?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Crinetics acromegaly drug succeeds in late

Guidelines to prevent youth baseball injuries need more muscle

What American doctors can learn from their Israeli counterparts

Heart attack and stroke risk calculators need revising

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

explore

Analysis of telehealth claims data suggest service duplication

Bristol 'take

House transparency, PBM reform bill gains bipartisan support

How generative AI is inspiring dreams of a health data revolution

The (many) problems with a new study criticizing cancer screening

Sana to lay off nearly a third of staff, de

leisure time

Wikipedia

hotspot

hotspot